Moffitt Cancer Center to Advance Breast Cancer Immunotherapy Research With $8.3 Million Grant From Department of Defense
October 01, 2019
October 01, 2019
TAMPA, Florida, Oct. 1 -- Moffitt Cancer Center issued the following news release:
Moffitt Cancer Center is kicking off Breast Cancer Awareness Month with the announcement of a new grant from the Department of Defense (DoD) to advance immunotherapy research for patients whose breast cancer has metastasized to the brain. The four-year, $8.3 million Breakthrough Award from the DoD's Breast Cancer Research Program will fund a phase 2 clinical trial led by Brian Czerniecki, M.D., Ph.D., . . .
Moffitt Cancer Center is kicking off Breast Cancer Awareness Month with the announcement of a new grant from the Department of Defense (DoD) to advance immunotherapy research for patients whose breast cancer has metastasized to the brain. The four-year, $8.3 million Breakthrough Award from the DoD's Breast Cancer Research Program will fund a phase 2 clinical trial led by Brian Czerniecki, M.D., Ph.D., . . .